← back to search
Xinfang Liang
Harbin Medical University
· CN
Area of research
Pharmaceutical Science · Infectious Diseases
Research interest
Research interests include Pyroptosis, PI3K/AKT/mTOR pathway, Inflammasome, Diabetic cardiomyopathy, Crosstalk, and Relaxin.
h-index
—
citations
25
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
H3 relaxin ameliorates mitochondrial quality control and apoptosis in cardiomyocytes of type 2 diabetic rats via activation of the AMPK pathway
International Immunopharmacology
2024
cited by
6
position: middle
doi
Ghrelin inhibits myocardial pyroptosis in diabetic cardiomyopathy by regulating ERS and NLRP3 inflammasome crosstalk through the PI3K/AKT pathway
Journal of drug targeting
2023
cited by
19
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Jingzhi Wang
· Peking University
2
papers (2023–2024)
Fan Wang
· Harbin Medical University
1
papers (2024–2024)
Jinfeng Wu
· Harbin Medical University
1
papers (2024–2024)
Chunnan Liu
· Shanghai Medical College of Fudan University
1
papers (2024–2024)
Fan Wang
· St. Jude Children's Research Hospital
1
papers (2023–2023)
Xinhua Yin
· Harbin Medical University
1
papers (2024–2024)
Jiaxin Xue
· Jiangsu University
1
papers (2023–2023)
Lingyu Yin
· Harbin Medical University
1
papers (2023–2023)
Xiaohui Zhang
· Shandong University
1
papers (2024–2024)
Zixuan Wu
· Beijing University of Chinese Medicine
1
papers (2023–2023)
Kelaier Yang
· Harbin Medical University
1
papers (2024–2024)
Xiaohui Zhang
· University of Illinois Chicago
1
papers (2023–2023)
Siting Hong
· Harbin Medical University
1
papers (2024–2024)
Lai Wei
· Google (United States)
1
papers (2023–2023)